Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
AEMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -2.88%76.640.8%$1071.33m
TMOThermo Fisher Scientific, Inc. -2.88%275.441.0%$865.21m
MDTMedtronic Plc -6.71%84.130.6%$856.00m
BDXBecton, Dickinson & Co. -1.91%225.381.1%$653.90m
ISRGIntuitive Surgical, Inc. -7.46%458.262.4%$652.39m
DHRDanaher Corp. -6.84%128.940.7%$641.66m
SYKStryker Corp. -13.17%144.571.3%$521.61m
BSXBoston Scientific Corp. -7.54%30.171.1%$467.64m
INOInovio Pharmaceuticals, Inc. 3.50%7.706.8%$449.25m
EWEdwards Lifesciences Corp. -8.34%172.891.2%$391.50m
DXCMDexCom, Inc. -5.37%254.818.2%$369.80m
BAXBaxter International, Inc. -3.25%78.551.8%$360.64m
ZBHZimmer Biomet Holdings, Inc. -11.20%89.761.7%$242.29m
IDXXIDEXX Laboratories, Inc. -4.78%230.663.8%$234.81m
ALGNAlign Technology, Inc. -9.63%157.206.4%$225.34m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.